Michael Dupont

Michael DuPont is an accomplished leader in the medical device and healthcare sectors, currently serving as Vice President of M&A at Getinge Group since January 2016, overseeing Mergers & Acquisitions, Divestments, and Strategic Alliances for the Acute Care Therapies Business Unit. With experience as a Board Member at Prytime Medical Devices, Inc. and as an Angel Investor with the NO/LA Angel Network, Michael is actively involved in supporting innovative medical solutions and early-stage companies. Prior roles include Vice President of New Business Development and Global Marketing at Maquet Getinge Group, and various positions at Atrium Medical and Pfizer Inc., where Michael achieved top sales performance accolades. Michael holds a B.S. in Biochemistry from Worcester Polytechnic Institute and has completed executive education programs at Harvard Business School and The Wharton School.